John Griffin is the Chief Business Officer at Kuros Biosciences, leveraging over 20 years of leadership in the medical device and biotech sectors. An alumnus of the Yale School of Management, he specializes in commercialization, strategic planning, and leading sales channels, guiding products from initial fundraising to market success.
He is the founder of Fort Point Medtech, a firm that partners with medical device and biotech companies to help them accelerate into their next commercial life-cycle stage.
Read the full overview →
Experience
24 Years
Current Role
Chief Business Officer
Job Level
Leadership
Location
Boston, Massachusetts, United States
Personality Overview
How John shows up
Relationship Oriented
Big Picture Person
Believer
They are friendly, approachable and love to make new connections. They are always positive and upbeat, so take their promises with a pinch of salt. They are really good at seeing what the long-term impacts of their decisions could be.
Priorities
Topics John cares about
Medtech Commercialization
He has over 20 years of experience creating value at all stages of the product life-cycle, from development and fundraising to commercial distribution and sales leadership.
Spine Repair Devices
As Area Sales Director at Benvenue Medical, he led sales and market development for minimally invasive systems for spine repair.
+5 more topicsLogin to view topics
Career
Work history
1-2026
Chief Business Officer
Kuros Biosciences
9-2023
Chief Commercial Officer (CCO)
Kuros Biosciences
4-2018 - 12-2023
Head Of Commercial Operations
Kuros Biosciences
11-2016
Principal
Fort Point Medtech, LLC
1-2015 - 5-2017
Area Sales Director
Benvenue Medical
In the press
Media appearances
John Griffin - Kuros Biosciences. Featured in Kuros Biosciences
Influence (I) reflects the degree to which a person prefers to work by influencing or persuading others. Those scoring high tend to be people oriented, motivated by social recognition and building relationships.
More profiles
Discover additional public profiles from our index.